Biotech co. settles case over low-GI sugar patent claims
Competition & Consumer Protection 2018-03-28 8:22 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

Australian biotech company Holista Colltech has resolved litigation over ASX announcements that said it was collaborating with a Nobel Prize nominee to file a patent for the world’s first low-GI sugar.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au